Showing results (71-80 of 103) with videos related to
Sort By:
Pageof 11
Journal of the American Academy of Dermatology|January 17, 2015
A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatosesTamar Hajar, Yael A Leshem, Jon M Hanifin, et al.JAAD International|May 22, 2024
Improving systemic therapy selection for inflammatory skin diseases: A clinical need surveyNicholas D Brownstone, Aaron S Farberg, Graham H Litchman, et al.The Journal of Dermatological Treatment|June 28, 2021
Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapyPeter A Lio, Eric L Simpson, George Han, et al.Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|March 3, 2006
Crystallization and X-ray diffraction analysis of salicylate synthase, a chorismate-utilizing enyme involved in siderophore biosynthesisJames F Parsons, Katherine Shi, Kelly Calabrese, et al.The Journal of Dermatological Treatment|June 1, 2026
Benefit-risk profile comparison between dupilumab and upadacitinib: a structured benefit-risk assessment of the Heads Up trialAndrew Blauvelt, Eric L Simpson, Kilian Eyerich, et al.Journal of Drugs in Dermatology : JDD|October 7, 2020
Atopic Dermatitis and the Role of the Skin Microbiome in Choosing Prevention, Treatment, and Maintenance OptionsHilary Baldwin, Crystal Aguh, Anneke Andriessen, et al.AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science|July 20, 2022
Predicting Unplanned 7-day Intensive Care Unit Readmissions with Machine Learning Models for Improved Discharge Risk AssessmentKatherine Shi, Vy Ho, Joanna J Song, et al.Dermatology and Therapy|June 26, 2024
Lebrikizumab Improves Quality of Life and Patient-Reported Symptoms of Anxiety and Depression in Patients with Moderate-to-Severe Atopic DermatitisPeter A Lio, April Armstrong, Jan Gutermuth, et al.Dermatology and Therapy|May 11, 2022
Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records DatasetLawrence F Eichenfield, April Armstrong, Emma Guttman-Yassky, et al.Eclinicalmedicine|July 3, 2023
Efficacy and safety of topically applied therapeutic ammonia oxidising bacteria in adults with mild-to-moderate atopic dermatitis and moderate-to-severe pruritus: a randomised, double-blind, placebo-controlled, dose-ranging, phase 2b trialJonathan I Silverberg, Peter A Lio, Eric L Simpson, et al.Pageof 11